Attached files

file filename
8-K - FORM 8-K - Nutrastar International Inc.form8k.htm

Nutrastar International, Inc. Announces Full Year 2014 Results

Harbin, China, March 30, 2015 -- Nutrastar International Inc. (OTCQB: NUIN; "Nutrastar" or the "Company"), a leading producer and supplier of premium branded consumer products, including commercially cultivated Cordyceps Militaris (“Cordyceps”), functional health beverages and organic and specialty foods, today announced its results for the full year ended December 31, 2014.

Financial Highlights for the Full Year Ended December 31, 2014

  • Net revenue was $43.33 million, as compared to $43.35 million in full year 2013.
  • Gross profit was $34.01 million, representing a gross margin of 78.5%.
  • Net income was $22.72 million, representing a net margin of 52.4%.
  • Basic and diluted EPS were $1.34 and $1.28, respectively, with 16.83 million basic shares and 17.70 million diluted shares outstanding.

Management Commentary

Ms. Lianyun Han, CEO of Nutrastar, commented, “Over the past few years, we have worked hard at expanding product offerings, increasing revenue and creating opportunities through product development and capacity expansion. Although revenue for 2014 came in slightly under our estimates, it was a successful year nonetheless marked by the expansion and realignment of our product offerings in order to better position ourselves to meet current and future market demand. For the full year 2014, we operated at full production capacity and with the benefit of these economies of scale, our gross margins improved to 78.5%, up from 77.8% in the prior year. We also experienced a sales increase of approximately 10% or $3.36 million in our core premium consumer product Cordyceps, which includes sales of our new soluble, on-the-go Cordyceps powder solution. As expected, due to the strategic product realignment implemented in early 2014, sales growth of our core Cordyceps product segment was partially offset by $3.47 million decrease in sales of our beverages product line, resulting in year-over-year flat revenue growth.”

Ms. Han continued, “Currently, we expect to continue operating at full production capacity and thus anticipate minimum year-over-year revenue growth in the current year. Since demand for our premium Cordyceps Militaris consumer products remains robust in our current markets, we will begin to evaluate avenues for future capacity expansion this year.

One of our 2015 priorities will be exploring opportunities and securing the export of our products to markets abroad. Since receiving initial export approval from China’s Ministry of Commerce as Foreign Trade Operator, we have been conducting and prototyping new product formats for select international markets such as South Korea and Hong Kong. We plan to evaluate and test our on-the-go soluble Cordyceps powder solution to determine its potential receptivity and viability in the U.S. market, and explore strategic packaging and distribution partners that will be integral to our international exportation approval and expansion efforts. It is our current intention to complete market testing, secure packaging and international distribution partners in 2015 and begin generating international sales revenue in 2016. We believe the international path is a vital part of the Company’s future growth plan and we are committed to ensuring it happens as soon as possible beginning with our powder solution. We will keep the public apprised as initiatives progress.


In closing, we believe 2015, despite our flat revenue growth expectations, will be a significant year that sets the stage for increased and sustained growth for the Company going forward. On behalf of the entire Nutrastar team, we would like to thank our shareholders and supporters for their continued patience and support for our Company and belief in our unique value proposition within the growing consumer product market. We look forward to sharing in our successes moving forward.”

Outlook for the Year Ending December 31, 2015

Based on management’s current expectations, full year 2015 revenue should be in the range of $43 million to $45 million.

Request for Call with Management

Investors are invited to request a call with Nutrastar’s management team. For those investors who are interested in speaking with management, please contact American Capital Ventures at +1-305-918-7000 to schedule.

For more information regarding Nutrastar’s financial performance during the full year ended December 31, 2014, please refer to the Annual Report on Form 10-K to be filed with the Securities and Exchange Commission on or about March 30, 2015.

About Nutrastar International Inc.

Nutrastar is a China based leading producer and supplier of premium branded consumer products including commercially cultivated Cordyceps Militaris, functional health beverages as well as specialty and organic foods. Cordyceps Militaris is one of the most highly regarded herbal nutrients in Traditional Chinese Medicine. The Company is headquartered in Harbin, capital of Heilongjiang Province, with 336 employees, including 21 in R&D, and 149 in sales and marketing. The products of Nutrastar are sold throughout China via a sales and distribution network that covers more than 10 provinces. More information may be found at http://www.nutrastarintl.com/ or e-mail: ir@nutrastarintl.com


Make sure you are first to receive timely up-to-date information on Nutrastar. Sign up for Nutrastar's email news alert system today at: http://www.nutrastarintl.com/alerts

Safe Harbor Statement

This news release contains “forward-looking statements” relating to the business of Nutrastar International Inc., its subsidiaries and other affiliate companies. All statements, other than statements of historical fact included herein are "forward-looking statements" including statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the Company with the Securities and Exchange Commission. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Other than as required under the securities laws, the Company does not assume a duty to update any forward-looking statements to reflect events or circumstances after the date hereof.

For more information, please contact:

Richard Hull
American Capital Ventures
Tel: +1-305-918-7000
Email: rh@amcapventures.com


NUTRASTAR INTERNATIONAL INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME
(AMOUNTS EXPRESSED IN US DOLLARS)

 

  Year Ended December 31,  

 

  2014     2013  

 

           

REVENUE

$  43,328,218   $  43,348,989  

 

           

Cost of goods sold

  (9,315,526 )   (9,633,349 )

 

           

GROSS PROFIT

  34,012,692     33,715,640  

 

           

Selling expenses

  (1,467,320 )   (1,848,488 )

General and administrative expenses

           

 

  (2,376,873 )   (3,216,459 )

Gain on re-measurement of accrued staff fringe and social benefits

  -     934,855  

 

           

Income from operations

  30,168,499     29,585,548  

 

           

Other income (expenses):

           

   Interest income

  399,696     324,145  

   Foreign exchange differences

  (10,765 )   64,653  

   Change in fair value of warrants

  -     173  

   Other income

  32,558     8,073  

   Total other income (expenses)

  421,489     397,044  

 

           

Income before income taxes

  30,589,988     29,982,592  

 

           

Provision for income taxes

  (7,870,214 )   (7,812,222 )

 

           

NET INCOME

  22,719,774     22,170,370  

 

           

OTHER COMPREHENSIVE INCOME:

           

Foreign currency translation adjustments

  (324,662 )   3,109,485  

 

           

COMPREHENSIVE INCOME

$  22,395,112   $  25,279,855  

 

           

Earnings per share

           

   Basic

$  1.34   $  1.38  

   Diluted

$  1.28   $  1.30  

 

           

Weighted average number of shares outstanding

           

   Basic

  16,827,010     15,949,537  

   Diluted

  17,699,589     17,089,460  


NUTRASTAR INTERNATIONAL INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(AMOUNTS EXPRESSED IN US DOLLARS)

 

  December 31,  

 

  2014     2013  

 

           

ASSETS  

 

CURRENT ASSETS

           

Cash and cash equivalents

$  126,542,564   $  102,599,186  

Accounts receivable

  93,066     56,922  

Inventories

  635,409     691,847  

Prepayments and other receivables

  1,489,800     1,300,012  

   Total current assets

  128,760,839     104,647,967  

OTHER ASSETS

           

Intangible assets, net

  613,315     1,107,737  

Property, plant and equipment, net

  14,424,942     15,481,249  

 

           

   Total assets

$  143,799,096   $  121,236,953  

 

           

LIABILITIES AND STOCKHOLDERS' EQUITY 

 

CURRENT LIABILITIES

           

Other payables and accruals

$  990,290   $  1,167,957  

Taxes payable

  2,748,583     2,879,172  

Due to a related party

  511,054     265,223  

Preferred stock dividend payable

  690,662     738,903  

   Total current liabilities

  4,940,589     5,051,255  

   Total liabilities

  4,940,589     5,051,255  

COMMITMENTS AND CONTINGENCIES

           

STOCKHOLDERS' EQUITY

           

Preferred Stock, $0.001 par value, 1,000,000 shares authorized, 77,776 shares and 110,066 shares issued and outstanding, respectively; aggregate liquidation preference amount: $2,177,728 and $3,081,848, plus accrued but unpaid dividend of $690,662 and $738,903, at December 31, 2014 and 2013, respectively

  1,773,772     2,510,183  

 

           

Common stock, $0.001 par value, 190,000,000 shares authorized, 16,953,541 shares issued and 16,909,986 shares outstanding at December 31, 2014; 16,421,161 shares issued and 16,377,606 shares outstanding at December 31, 2013

  16,954     16,422  

Additional paid-in capital

  21,122,372     19,934,551  

Statutory reserves

  4,989,033     4,983,935  

Treasury stock, at cost, 43,555 shares as of December 31, 2014 and 2013

  (78,767 )   (78,767 )

Retained earnings

  102,783,308     80,242,877  

Accumulated other comprehensive income

  8,251,835     8,576,497  

   Total stockholders' equity

  138,858,507     116,185,698  

 

           

   Total liabilities and stockholders' equity

$  143,799,096   $  121,236,953  


NUTRASTAR INTERNATIONAL INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(AMOUNTS EXPRESSED IN US DOLLARS)

 

  Year Ended December 31,  

 

  2014     2013  

CASH FLOWS FROM OPERATING ACTIVITIES:

           

Net income

$  22,719,774   $  22,170,370  

Adjustments to reconcile net income to cash provided by operating activities:

       

   Change in fair value of warrants

  -     (173 )

   Depreciation and amortization

  1,485,039     1,473,496  

   Share-based compensation expense

  137,085     801,396  

   IR unregistered stock compensation expense

  92,371     17,804  

(Increase) decrease in assets:

           

                 Accounts receivable

  (36,209 )   26,676  

                 Inventories

  53,730     298,548  

                 Prepayments and other receivables

  (193,731 )   61,626  

Increase (decrease) in liabilities:

           

                 Other payables and accruals

  (173,184 )   -  

                 Advance from related party

  237,956     (351,591 )

                 Taxes payable

  (119,724 )   (191,162 )

        Net cash provided by operating activities

  24,203,107     24,306,990  

 

           

CASH FLOWS FROM FINANCING ACTIVITIES:

           

   Advance from related party

  16,637     46,173  

        Net cash provided by financing activities

  16,637     46,173  

 

           

Foreign currency translation adjustment

  (276,366 )   2,719,490  

 

           

INCREASE IN CASH AND CASH EQUIVALENTS

  23,943,378     27,072,653  

CASH AND CASH EQUIVALENTS, at the beginning of the period

  102,599,186     75,526,533  

 

           

CASH AND CASH EQUIVALENTS, at the end of the period

$  126,542,564   $  102,599,186  

 

           

NON-CASH TRANSACTIONS

           

Preferred stock and dividend converted into common stock

$  958,897   $  86,279  

Preferred stock dividend payable

  174,245     229,513  

Share-based payment to officers and directors under equity incentive plan

  137,085     801,396  

Share-based payment – IR unregistered stock compensation expense

  92,371     17,804  

SUPPLEMENTAL DISCLOSURE INFORMATION

           

Income taxes paid

$  7,970,444   $  7,683,689